Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. M. Gust
Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Role of Fibroblast Growth Factor Receptor 2 in Pancreatic Cancer: Potential Target for New Therapeutic Approach?
Pancreatic Disorders and Therapy
Fibroblast Growth Factor Receptor 3-IIIc Mediates Colorectal Cancer Growth and Migration
British Journal of Cancer
Cancer Research
Oncology
Insulin-Like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer
Clinical Cancer Research
Cancer Research
Oncology
Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
PLoS ONE
Multidisciplinary
EZH2 in Bladder Cancer, a Promising Therapeutic Target
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer
Clinical Cancer Research
Cancer Research
Oncology
Skeletal Overgrowth Is Mediated by Deficiency in a Specific Isoform of Fibroblast Growth Factor Receptor 3
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Fibroblast Growth Factor Receptor (FGFR)
Science-Business eXchange
Validation of the Type 1 Insulin-Like Growth Factor Receptor as a Therapeutic Target in Renal Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology